Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors

ME Cabanillas, R Dadu, P Iyer, KB Wanland… - Thyroid, 2020 - liebertpub.com
Background: The BRAFV600E mutation is the most common driver mutation in papillary
thyroid cancer (PTC) and anaplastic thyroid cancer (ATC). This mutation is considered …
被引用次数：80 相关文章

Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors

ME Cabanillas, R Dadu, P Iyer, KB Wanland… - …, 2020 - mdanderson.elsevierpure.com
The BRAFV600E mutation is the most common driver mutation in papillary thyroid cancer
(PTC) and anaplastic thyroid cancer (ATC). This mutation is considered actionable and, for …
[HTML] nih.gov

[HTML][HTML] Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors

ME Cabanillas, R Dadu, P Iyer, KB Wanland… - Thyroid, 2020 - ncbi.nlm.nih.gov
Background: The BRAF V600E mutation is the most common driver mutation in papillary
thyroid cancer (PTC) and anaplastic thyroid cancer (ATC). This mutation is considered …

Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors.

ME Cabanillas, R Dadu, P Iyer… - … : Official Journal of the …, 2020 - europepmc.org
Background: The BRAF V600E mutation is the most common driver mutation in papillary
thyroid cancer (PTC) and anaplastic thyroid cancer (ATC). This mutation is considered …

Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors.

ME Cabanillas, R Dadu, P Iyer, KB Wanland… - …, 2020 - search.ebscohost.com
Abstract Background: The BRAF< sup> V600E</sup> mutation is the most common driver
mutation in papillary thyroid cancer (PTC) and anaplastic thyroid cancer (ATC). This …

Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors

ME Cabanillas, R Dadu, P Iyer… - … : official journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background: The BRAF V600E mutation is the most common driver mutation in papillary
thyroid cancer (PTC) and anaplastic thyroid cancer (ATC). This mutation is considered …